Rozlyn S. Lipsey - 25 Oct 2021 Form 3 Insider Report for MedMen Enterprises, Inc.

Role
COO
Signature
/s/ Rozlyn S. Lipsey
Issuer symbol
N/A
Transactions as of
25 Oct 2021
Net transactions value
$0
Form type
3
Filing time
03 Nov 2021, 19:54:39 UTC
Next filing
14 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MMNFF Class B Subordinate Voting Shares 183,844 25 Oct 2021 Direct
holding MMNFF Class B Subordinate Voting Shares 866,683 25 Oct 2021 Direct F1
holding MMNFF Class B Subordinate Voting Shares 511,727 25 Oct 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMNFF Employee Stock Options (right to buy) 25 Oct 2021 Class B Subordinate Voting Shares 10,000 $3.42 Direct F3, F4, F5
holding MMNFF Employee Stock Options (right to buy) 25 Oct 2021 Class B Subordinate Voting Shares 247,185 $0.1670 Direct F3, F6
holding MMNFF Employee Stock Options (right to buy) 25 Oct 2021 Class B Subordinate Voting Shares 128,848 $0.2814 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"), granted 9/9/2020 pursuant to Issuer's 2018 Stock and Incentive Plan (the "Incentive Plan"), which vest annually over four years with 37.5% vesting on 6/30/2021 and 6/30/2023, and 12.5% vesting on 6/30/2022 and 6/30/24. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
F2 Represents RSUs granted 8/29/2021 pursuant to the Incentive Plan, which vest annually over four years with 37.5% vesting on 6/30/2022 and 6/30/2024, and 12.5% vesting on 6/30/2023 and 6/30/25. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
F3 Employee stock options (right to buy) ("Options") granted pursuant to the Incentive Plan.
F4 Options vest over four years with 25% vesting on January 7, 2020. The balance vest equally on a monthly basis thereafter.
F5 Such Options have an exercise price of CAN$4.53, which is equivalent to US$3.42 at an exchange rate of 0.7544 as of the grant date.
F6 Such Options have an exercise price of CAN$0.22, which is equivalent to US$0.1670 at an exchange rate of 0.7591 as of the grant date.
F7 Such Options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 0.7925 as of the grant date.